Like the Sword of Damocles of Greek myth, market price reporting by labs under the Protecting Access to Medicare Act (PAMA) continues to hang over the heads of the nation’s clinical laboratories. However, instead of a threat, PAMA market price reporting may soon become a reality. News reports indicate that, as of April 21, the White House Office of Management and Budget (OMB) had begun its review of the final rule as written by the federal Centers for Medicare & Medicaid Services.
MORE ON: PAMA Price Reporting
A date for implementation of market price reporting for lab tests has not been announced. Congress had mandated that the final rule be released by June 30, 2015, so CMS is almost a full year behind that timetable. Section 216 of the PAMA law establishes January 1, 2017, as the date when CMS is to implement new prices determined by the market price data submitted by labs.
FASTING FOR BLOOD CHOLESTEROL TEST
Overnight fasting is not needed for a blood cholesterol test. That is the recomendation of the European Atherosclerosis Society and the European Federation of Clinical Chemistry. Details of the recomendation and the study supporting it were published in the European Heart Journal last month. (http://tinyurl.com/zb6249b)
- Mark Powelson was promoted to President and CEO of XCR Diagnostics of Park City, Utah. Prior to joining XCR, Powelson was with DeNovo Sciences, HandyLab, Gen-Probe, and Boehringer-Manheim.
- Sequenom of San Diego appointed Glenn Magnuson as Vice President of Sales. He previously held executive positions at T2 Biosystems, Thermo Fisher Scientific, Cytyc Corporation, and Abbott Diagnostics.
- Human Longevity, Inc., of San Diego promoted Kenneth Bloom, MD, to President, where he now reports to Craig Venter, PhD, HLI’s CEO and co-founder. Bloom formerly served at Clarient and US Labs.
- Roberta Provencal died suddenly last month at age 62. She was Executive Director, Laboratory and Outpatient Rehab at Catholic Medical Center in Manchester, New Hampshire. She had previously held leadership positions in the laboratories of Concord Hospital, Brockton Hospital, and Elliot Hospital.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…the emerging business of brokering healthcare data. Third-party brokers represent an opportunity for labs to dollarize their lab test data, but issues of how to anonymize data and protect patient privacy need to be resolved.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.
That’s all the insider intelligence for this report. Look for the next briefing on Monday, May 23, 2016.
∗ Getting Paid for Molecular and Genetic Tests: Two Experts Offer Insights and Advice
∗ Serving Millennials with Lab Testing: Important Lessons from Lab Innovators
∗ Tougher Times Ahead for Anatomic Pathology: How Successful Path Groups Are Preparing